Advertisement

Ethical and Other Issues of Genetic Testing

  • Seymour Garte
Part of the Developments in Oncology book series (DION, volume 79)

Abstract

Genetic susceptibility to cancer is a subject with far reaching and very difficult ethical and legal implications (Eng and Vijg 1997, Patenaude 1996, Kadlec and McPherson 1995, Vineis and Schulte 1995). The ethical issues are complex and may divided in a variety of ways. One useful way to categorize the ethical issues related to genetic cancer susceptibility is to consider categories of issues related to research, issues related to clinical practice, and issues related to public health and screening. Of course many of the critical points to made on this subject apply to more than one of these categories, but some are unique to one or two of them.

Keywords

Genetic Testing Cancer Susceptibility Large Scale Screening Future Health Status Genetic Susceptibility Testing 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Beckmann MW, Schnurchzz HG, Bodden-Heidrich R, Mosnyzz DS, Crombachzz G, Nitzzz U, Achnoulazz M, Bender HG. (1996) Early cancer detection programmes for women at high risk for breast and ovarian cancer: a proposal of practical guidelines. European Journal of Cancer Prevention 5: 468–475.PubMedGoogle Scholar
  2. Berchuck A, Cirisanozz F, Lancasterzz JM, Schildkrautzz JM, Wisemanzz RW, Futrealzz A, Marks JR. (1996) Role of BRCA1 mutation screening in the management of familial ovarian cancer. American Journal of Obstetrics & Gynecology 175: 738–746.CrossRefGoogle Scholar
  3. Clayton EW, Steinbergzz KK, Khouryzz MJ, Thomsonzz E, Andrewszz L, Kahnzz MJE, Kopelmanzz LM, Weiss JO. (1995) Informed consent for genetic research on stored tissue samples. J American Med Assoc 274: 1786–1792.CrossRefGoogle Scholar
  4. Eng C, Vijg J. (1997) Genetic testing: the problems and the promise. Nature Biotechnology 15: 422–426.PubMedCrossRefGoogle Scholar
  5. Geller G, Botkinzz JR, Greenzz MJ, Presszz N, Bieseckerzz BB, Wilfondzz B, Granazz G, Dalyzz MB, Schneiderzz K, Kahn MJ. (1997) Genetic testing for susceptibility to adult-onset cancer. The process and content of informed consent. JAMA 277: 1467–1474.PubMedCrossRefGoogle Scholar
  6. Hunter D, Caporaso N. (1997) Informed consent in epidemiologic studies involving genetic markers. Epidemiology 8: 596–599.PubMedGoogle Scholar
  7. Kadlec JV, McPherson RA. (1995) Ethical issues in screening and testing for genetic diseases. Clinics in Laboratory Medicine 15: 989–999.PubMedGoogle Scholar
  8. Patenaude AF. (1996) The genetic testing of children for cancer susceptibility: ethical, legal, and social issues. Behavioral Sciences & the Law 14: 393–410.CrossRefGoogle Scholar
  9. Van Damme K, Casteleyn L. (1998) Ethical, social and scientific problems related to the application of genetic screening and genetic monitoring for workers in the context of a European approach to health and safety at work. Medicina del Lavoro 89: S71–S72.Google Scholar
  10. Vineis P, Schulte PA. (1995) Scientific and ethical aspects of genetic screening of workers for cancer risk: the case of the N-acetyltransferase phenotype. Journal of Clinical Epidemiology 48: 189–197.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Seymour Garte
    • 1
  1. 1.University of Medicine and Dentistry of New Jersey New York University Medical CenterUSA

Personalised recommendations